Defibrillators Market: Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2021-2027

Defibrillators are devices used to deliver therapeutic shock to a patient’s heart in life-threatening conditions such as ventricular fibrillation, cardiac arrhythmia, and pulseless ventricular tachycardia.

Defibrillator Market Report, published by Allied Market Research, forecasts that the global market is expected to garner $15,610 million by 2027, during the forecast period 2014-2027. Implantable cardioverter defibrillators (ICDs) segment is expected to dominate this market throughout 2015 and 2027.

North America would continue to lead, accounting for more than two-fifths share of the global defibrillator market in 2015.

The transvenous-implantable cardioverter defibrillator (T-ICDs) segment accounted for about 95% of the overall ICD market in 2015, as these are the most commonly used ICD's for the treatment of heart disorders for higher precision and targeted functioning. In addition, cardiac resynchronization therapy defibrillator (CRT-D) is the fastest growing segment and is projected to register a CAGR 5.0% during the forecast period.

This is due to the growing demand of defibrillator that helps in restoring the heart back to a normal pace from faster heart rhythms and to prevent the heart rate to go below normal levels.

Download Free Sample Report @ www.alliedmarketresearch.com/request-sample/1434

Automated external defibrillator (AEDs) segment is projected to maintain its lead in the overall external defibrillators market due to its increasing installations at public or private places such as schools, work place, airports, sports arenas, government offices, and others. The growing demand of AEDs in the developed economies of North America and Europe have further boosted the market growth.

Furthermore, wearable external defibrillator is anticipated to exhibit the highest growth, with a CAGR of 12.3% during the forecast period. This is owed to the advanced protection by these defibrillators for sudden cardiac arrest and increase in demand from home healthcare facilities.

North America accounted for the majority of revenue in 2015 and is expected to maintain its dominance throughout the forecast period. This is attributed to the increased adoption of advanced defibrillators, increased awareness about public access defibrillator, increased procedure volumes resulting from rapidly aging population, and increasing incidence of cardiovascular diseases and sudden cardiac arrest (SCA).

Moreover, improvement in healthcare expenditure further boosts the sale of home care defibrillators such as wearable external defibrillators and automated external defibrillator (AEDs).

Key findings of the study:

In 2015, T-ICDs led the overall implantable defibrillator market revenue, and is projected to grow at a CAGR of 4.9% during the forecast period.

Wearable external defibrillator segment is expected to grow at a remarkable CAGR of 12.3%, owing to the non-invasive nature and increased demand of home healthcare for the treatment of sudden cardiac arrest.

Fully-automated defibrillator segment is projected to grow at a CAGR of 9.9% during the analysis period.

The automated external defibrillator (AEDs) is projected to generate the largest revenue in the world external defibrillator market.

Japan is the major shareholder accounting for about half share of the Asia-Pacific defibrillators market.

Regional Analysis:

The market is analyzed based on regions and competitive landscape in each region is mentioned. Regions discussed in the study include North America (United States, Canada and Mexico), Europe (Germany, France, UK, Russia and Italy), Asia-Pacific (China, Japan, Korea, India and Southeast Asia), South America (Brazil, Argentina, and Colombia), Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa).

These insights help to devise strategies and create new opportunities to achieve exceptional results.

Inquiry for Report @ https://www.alliedmarketresearch.com/purchase-enquiry/1434

The key players in the defibrillators market are focused on expanding their business operations in the fast-growing emerging countries with new product launches as a preferred strategy. The major players profiled in this report include ZOLL Medical Corporation (a subsidiary of Asahi Kasei Corporation), Stryker Corporation, Biotronik SE & Co.

KG, Boston Scientific Corporation, LivaNova PLC, Medtronic plc, Koninklijke Philips N.V., Defibtech, LLC, St. Jude Medical, Inc., Nihon Kohden Corporation, and Cardiac Science Corporation.

Sample of the Defibrillator Market Report can be accessed on Website: https://www.alliedmarketresearch.com/defibrillator-market

Contact Info:
Name: David Correa
Email: Send Email
Organization: Allied Market Research
Address: 5933 NE Win Sivers Drive #205, Portland, OR 97220 United States
Phone: +1-800-792-5285, +1-503-894-6022, +1-503-446-1141
Website: https://www.alliedmarketresearch.com/

Release ID: 89030024